Effects of Obesity on Outcomes in Endoscopically Assisted Coronary Artery Bypass Operations
DOI:
https://doi.org/10.1532/hsf.569Abstract
Background: Obesity has been shown to be an independent risk factor for adverse outcomes and prolonged hospitalization following conventional coronary artery bypass (CAB). For this reason and because of increased technical challenges, obesity has been considered a relative contraindication for minimally invasive bypass. The purpose of this study was to determine if in fact severe or morbid obesity is an independent risk factor for patients undergoing minimally invasive CAB.
Methods: Outcome data of 350 consecutive endoscopic, atraumatic CAB procedures performed at our institution over a 4-year period were reviewed with respect to patient body mass index (BMI). All operations consisted of thoracoscopic left or right internal mammary artery (IMA) harvesting followed by off-pump grafting of the left anterior descending (with/without diagonal coronary artery) or right coronary artery via a 4-cm thoracotomy. Patients were divided into 4 groups: small (BMI £ 24 kg/m2), normal to mild obesity (24 kg/m2 < BMI 34 kg/m2), severe obesity (34 kg/m2 < BMI £ 40 kg/m2), and morbid obesity (BMI >40 kg/m2). Results: Although the BMI >34 kg/m2 groups had a higher incidence of hypertension, diabetes, and hypercholesterolemia, there was no statistical difference in operative risk between groups. Thirty-day mortality, conversion to sternotomy, transfusion rate, and wound, pulmonary, neurological, and myocardial complications were not significantly different between groups. The BMI >34 kg/m2 patients required longer IMA harvest times and total operating times, but the intensive care unit length of stay was not significantly different between groups. Hospital length of stay was longer for the BMI £ 24 kg/m2 group than for the BMI 18 to 34 kg/m2 group (P = .025). Conclusion: Despite increased technical difficulty caused by obesity, it is not an independent risk factor for patients undergoing minimally invasive CAB.
References
[WHO] World Health Organization. 1998. Obesity: preventing and managing the global epidemic: report of a WHO Consultation on Obesity, Geneva; June 3-5, 1997. Geneva, Switzerland: WHO.nYamagishi T, Ishikawa S, Ohtaki A, Takahashi T, Ohki S, Morishita Y. 2000. Obesity and postoperative oxygenation after coronary artery bypass grafting. Jpn J Thorac Cardiovasc Surg 48:632-6.nBader DS, Maguire T, Spahn C, O'Malley C, Balady G. 2001. Clinical profile and outcomes of obese patients in cardiac rehabilitation stratified according to National Heart, Lung, and Blood Institute criteria. J Cardiopulm Rehabil 21:210-7.nBirkmeyer N, Charlesworth D, Hernandez F, et al. 1998. Obesity and risk of adverse outcomes associated with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 97:1689-94.nBrandt M, Harder K, Walluscheck K, et al. 2001. Severe obesity does not adversely affect perioperative mortality and morbidity in coronary artery bypass surgery. Eur J Cardiothorac Surg 19:662-6.nCriqui MH, Klauber MR, Barrett-Connor E, Holdbrook MJ, Suarez L, Wingard DL. 1982. Adjustment for obesity in studies of cardiovascular disease. Am J Epidemiol 116:685-91.nEngelman D, Adams D, Byrne J, et al. 1999. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg 118:866-73.nGurm H, Whitlow P, Kip K. 2002. The impact of body mass index on short- and long-term outcomes in patients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 39:834-40.nRanucci M, Cazzaniga A, Soro G, Morricone L, Enrini R, Caviezel F 1999. Obesity and coronary artery surgery. J Cardiothorac Vasc Anesth 13:280-4.nSchwann T, Habib R, Zacharias A, et al. 2001. Effects of body size on operative, intermediate, and long-term outcomes after coronary artery bypass operation. Ann Thorac Surg 71:521-31.nVassiliades T. 2001. Atraumatic coronary artery bypass (ACAB): technique and outcome. Heart Surg Forum 4:331-4.n
Published
How to Cite
Issue
Section
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).
